Epicrispr Biotechnologies is a biotechnology enterprise that focuses on epigenetic engineering.
Epicrispr Biotechnologies has raised $8.0M in total funding. The most recent round was Grant. The last funding was announced in October 2026.
Epicrispr Biotechnologies's investors include Janus Henderson Investors, Fidelity, Cormorant Asset Management, Angelini Ventures, Sanofi Ventures.
Epicrispr Biotechnologies is headquartered in South San Francisco, United States.
Epicrispr Biotechnologies is a biotechnology enterprise that focuses on epigenetic engineering.
Epicrispr Biotechnologies is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Epicrispr Biotechnologies — Funding & Investors." VCBacked, October 19, 2026, https://www.vcbacked.co/company/epicrispr-biotechnologies. Accessed November 11, 2026.
VCBacked. (2026). Epicrispr Biotechnologies — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/epicrispr-biotechnologies
{{cite web |title=Epicrispr Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/epicrispr-biotechnologies |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Epicrispr Biotechnologies? Request a listing update